ASSESSING RENAL OUTCOMES IN ATRIAL FIBRILLATION PATIENTS WITH PRE-EXISTING RENAL DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RIVAROXABAN VERSUS VITAMIN K ANTAGONISTS.

MLA

Van Sy, Hoang, et al. “Assessing Renal Outcomes in Atrial Fibrillation Patients with Pre-Existing Renal Disease: A Systematic Review and Meta-Analysis of Rivaroxaban Versus Vitamin K Antagonists.” Journal of the American College of Cardiology (JACC), vol. 83, no. 13, Apr. 2024, p. 76. EBSCOhost, https://doi.org/10.1016/S0735-1097(24)02066-7.

APA

Van Sy, H., Ton that, M., Tri, H. H. Q., Nguyen, H. H., Cao, S. L., Tran, S. G., Pham, H. M., Phan, P. D., Pham, H. N., & Vu, Q. N. (2024). Assessing Renal Outcomes in Atrial Fibrillation Patients with Pre-Existing Renal Disease: A Systematic Review and Meta-Analysis of Rivaroxaban Versus Vitamin K Antagonists. Journal of the American College of Cardiology (JACC), 83(13), 76. https://doi.org/10.1016/S0735-1097(24)02066-7

Chicago

Van Sy, Hoang, Minh Ton that, Ho Huynh Quang Tri, Hai Hoang Nguyen, Son Luong Cao, Song Giang Tran, Hung Manh Pham, Phong Dinh Phan, Hung N. Pham, and Quynh Nga Vu. 2024. “Assessing Renal Outcomes in Atrial Fibrillation Patients with Pre-Existing Renal Disease: A Systematic Review and Meta-Analysis of Rivaroxaban Versus Vitamin K Antagonists.” Journal of the American College of Cardiology (JACC) 83 (13): 76. doi:10.1016/S0735-1097(24)02066-7.